Ignite Creation Date:
2024-05-06 @ 12:58 PM
Last Modification Date:
2024-10-26 @ 1:06 PM
Study NCT ID:
NCT03892525
Status:
TERMINATED
Last Update Posted:
2021-07-26
First Post:
2019-03-26
Brief Title:
Study of Intratumoral Selicrelumab With Atezolizumab in Patients With Refractory or Relapsed B Cell Lymphoma
Sponsor:
Organization:
The Lymphoma Academic Research Organisation